For the first time in U.S. history, a commercial nuclear reactor tests fuel enriched above the traditional 5 per cent threshold, marking a milestone in nuclear energy development.
Tim Boerkamp, Founder & Philosophy Writer at Examined Mind, a platform for practical philosophy, argues that philosophy is a skill rather than just a subject.
An AI-powered lung ultrasound tool has outperformed human experts in diagnosing pulmonary tuberculosis (TB), offering a faster, non-invasive alternative that exceeds WHO benchmarks.
Cambridge researchers have partnered with Bloomberg to launch the first global bond index targeting fossil fuel expansion. This aims to steer investment towards real-economy emissions reductions, offering a novel approach for climate-conscious asset owners in crucial debt markets.
The UK government has announced a £121 million investment in quantum technology to strengthen its position as a global leader in emerging technologies.
A landmark study presented at ESCMID Global 2025 reveals the devastating impact of antimicrobial resistance (AMR) on children's health. In 2022, over 3 million children worldwide died from antibiotic-resistant infections, highlighting the urgent need for global action.
Ali Farooqui, Head of Cyber Security at BJSS, now part of CGI, explores how companies can balance the benefits of artificial intelligence (AI) with robust cybersecurity practices.
Why are dampness, condensation, and mould still issues, and how do I know if the building I live, work, or learn in is healthy? Cornerstone Management Limited responds here.
To help strengthen marine conservation and climate resilience, the United Kingdom has launched its Climate and Ocean Adaptation and Sustainable Transition (COAST) programme in the Philippines.
Northern Ireland's Wrightbus has announced a £25 million investment into cutting-edge research and development that is expected to accelerate the production of next-generation electric and hydrogen-powered buses.
The European Commission has launched a consultation initiative to shape the future of artificial intelligence (AI) in science and make the EU a global leader in AI-driven research and innovation.
Liverpool is set to revolutionise infectious disease research with a new AI-powered robotics lab, backed by £10m Innovation Zone funding. These advanced labs will accelerate the development of life-saving treatments for deadly pathogens, boosting the region's life sciences leadership.
The draft guidance will improve access to vital rehabilitation services for millions of people living with long-term neurological conditions in England.
